Navigation Links
Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany
Date:12/27/2011

not limited to, uncertainties relating to: the future use and adoption of the CHEMOSAT system by the J.W. Goethe University Hospital,  future initial launch and training agreements with other cancer centers in Europe, CE Marking for the Generation Two system and the timing of our commercial launch in Europe, the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
2. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
3. Delcath to Present at the Lazard Healthcare Conference on November 15
4. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
5. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
6. FDA Schedules Delcath Pre-New Drug Application Meeting Date
7. Delcath Announces Completion of Regulatory Notification Process in New Zealand
8. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
9. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
10. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
11. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  IRIDEX Corporation (NASDAQ: ... release its second quarter 2014 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, July ... quarter and other business developments. Interested parties ...
(Date:7/24/2014)... 24, 2014 Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... 31, to discuss the Company,s Second Quarter 2014 ... 2014 earnings conference call and webcastWhen: , ... Lipps, chairman, president and chief executive officer ...
(Date:7/24/2014)... Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty ... for the second quarter ended June 30, 2014. ... $6.5 million in the second quarter of 2014, an increase ... Total revenues of $13.3 million for the six months ended ... period in 2013 , Total revenues generated from the ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... MINNEAPOLIS, Jan. 19, 2012 Zyga Technology, Inc. announced ... the company and will serve as Vice President of ... (Logo: http://photos.prnewswire.com/prnh/20110118/CG30384LOGO ) Joe ... Medical Device Industry.  He began his career at Codman ...
... Berkery Noyes, an independent middle market investment bank, today ... trend report for the Pharma & Healthcare ... report analyzes the sector for 2011 and compares it ... includes information and technology companies servicing pharmaceutical, healthcare payer, ...
Cached Medicine Technology:Zyga Technology, Inc. Makes Two Key Additions to the Sales Leadership Team 2Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report 2Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report 3
(Date:7/25/2014)... Tucson, AZ (PRWEB) July 25, 2014 ... Solutions , a Nuanced Media client and the ... medical and dental employee handbooks, announced their partnership ... , TransAct is a registered ISO/MSP of Chase ... in the transaction processing industry. Companies that are ...
(Date:7/25/2014)... This is a professional and in-depth ... (GOS) industry in Global and China. The ... including definitions, applications and industry chain structure. Global ... provided with a focus on history, developments, trends ... between the international and Chinese situation is also ...
(Date:7/25/2014)... 2014 Drexel University College of Medicine ... MS, FACP, has been appointed vice dean for education, effective ... from The Commonwealth Medical College, where she is currently chair ... affairs, and professor of medicine. , As a member ... Weber had a major role in many aspects of the ...
(Date:7/25/2014)... 24, 2014 (HealthDay News) -- Shift workers, especially men, may ... people not on such schedules, a new study suggests. ... on a set schedule, with shifts moving around at various ... all surprising," said one expert, Dr. Alan Manevitz, a clinical ... "Physicians have long known that working shifts disrupts many key ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay --, Treatment for lymphoma ... Hodgkin lymphoma and non-Hodgkin lymphoma, which are cancers of ... who are still in their reproductive years. For men, ... production. Although most men regain their fertility within two ... be counseled about the possibility of this significant side ...
Breaking Medicine News(10 mins):Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:Lymphoma Treatment May Harm, Halt Men's Sperm Production 2
... By Amanda Gardner HealthDay Reporter , TUESDAY, May ... preliminary, genetic test that seems to predict which breast cancer ... in turn, could greatly help guide treatment, according to a ... of the American Medical Association . The findings are ...
... , TUESDAY, May 10 (HealthDay News) -- Shortages of anesthetics ... of a new survey. The findings revealed that more ... 1,350 from the United States) are experiencing a shortage of ... percent of the respondents encountered a similar problem, the poll ...
... 10 (HealthDay News) -- Many tanning salons in the United ... cancer risks posed by tanning beds, according to a new ... more than 3,800 white females aged 14 to 22 from ... attitudes and behavior. The survey found that 43 percent ...
... About 14 percent of strokes happen while people are sleeping, ... the hospital in time for a potentially brain-saving treatment, a ... ischemic stroke must be given within a few hours after ... symptoms often can,t receive the treatment since we can,t determine ...
... the disturbing act of self-injury is nothing new to ... identified a more severe type of behavior that is ... and under-reported, Self-Embedding Behavior (SEB) is a form of ... tissue either under the skin or into muscle. ...
... the prevalence of overall cardiovascular risk in the Spanish working ... risk (8% on men and 2% in women). This prevalence ... the farming sector, followed by construction, industry and services. ... level of cardiovascular risk, but only a minority of these ...
Cached Medicine News:Health News:Genetic Test Shows Promise in Guiding Breast Cancer Care 2Health News:Genetic Test Shows Promise in Guiding Breast Cancer Care 3Health News:Shortage of Anesthetics Reported 2Health News:Too Few Teens Know the Dangers of Tanning Beds: Poll 2Health News:Research Suggests 1 in 7 Strokes Happens During Sleep 2Health News:A new study on self-injury behavior encourages quick and targeted intervention 2Health News:6 percent of Spanish workers have high cardiovascular risk 2
The Shandon Citadel is a low cost, reliable, time-tested carousel-type tissue processor with convenient touch key operation. The Citadel 2000 has 110 cassette capacity and the Citadel 1000 has a cap...
... Senior Grossing Wokrstation is a durable, ... for gross examination and sectioning of ... 3 efficient ventilation systems and options ... water faucets, table rinses, disposals and ...
The HypercleanTM 1 is a versatile, durable fume handling station. The Hyperclean 1 fume handling station unit comes complete with one (1) blower unit and one (1) charcoal filter....
... Gross-Star Grossing Workbench is a durable, ... gross examination and sectioning of specimens. ... ventilation with a choice of 3 ... for cold/hot water faucet, optional formalin ...
Medicine Products: